Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy. | J Med Chem | 2023 | 37134182 | PubTator, text mining | PubMed |
| Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations. | BJOG | 2023 | 37132126 | PubTator, text mining | PubMed |
| A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer. | Br J Cancer | 2023 | 37120671 | PubTator, text mining | PubMed |
| Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature. | Fam Cancer | 2023 | 37119509 | PubTator, text mining | PubMed |
| Germline DNA-Repair Genes and HOXB13 Mutations in Korean Men with Metastatic Prostate Cancer: Data from a Large Korean Cohort. | World J Mens Health | 2023 | 37118955 | PubTator, text mining | PubMed |
| Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar score. | Breast | 2023 | 37116400 | PubTator, text mining | PubMed |
| Correlation of preclinical and clinical biomarkers with efficacy and toxicity of cancer immunotherapy. | Ther Adv Med Oncol | 2023 | 37113734 | PubTator, text mining | PubMed |
| Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence. | Metabolites | 2023 | 37110218 | PubTator, text mining | PubMed |
| Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA. | Int J Mol Sci | 2023 | 37108398 | PubTator, text mining | PubMed |
| What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. | Cancer Med | 2023 | 37096751 | PubTator, text mining | PubMed |
| The Unique Spectrum of MUTYH Germline Mutations in Colombian Patients with Extracolonic Carcinomas. | Appl Clin Genet | 2023 | 37096204 | PubTator, text mining | PubMed |
| Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature. | Thorac Cancer | 2023 | 37095004 | PubTator, text mining | PubMed |
| Multi-omics analysis of the Indian ovarian cancer cohort revealed histotype-specific mutation and gene expression patterns. | Front Genet | 2023 | 37091785 | PubTator, text mining | PubMed |
| Associations of breast cancer etiologic factors with stromal microenvironment of primary invasive breast cancers in the Ghana Breast Health Study. | Res Sq | 2023 | 37090574 | PubTator, text mining | PubMed |
| Fanconi anemia-associated chromosomal radial formation is dependent on POLθ-mediated alternative end joining. | Cell Rep | 2023 | 37086407 | PubTator, text mining | PubMed |
| The association between age at breast cancer diagnosis and prevalence of pathogenic variants. | Breast Cancer Res Treat | 2023 | 37084156 | PubTator, text mining | PubMed |
| Next-generation sequencing study on poorly differentiated carcinoma derived from a thirty-year-old epidermoid cyst: A case report. | Front Oncol | 2023 | 37077824 | PubTator, text mining | PubMed |
| Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2. | Br J Cancer | 2023 | 37076566 | PubTator, text mining | PubMed |
| Aggressive progression to EGFR tyrosine kinase inhibitors in advanced NSCLC patients: concomitant mutations, prognostic indicator and subsequent management. | J Cancer Res Clin Oncol | 2023 | 37074454 | PubTator, text mining | PubMed |
| Health Disparities in Presentation, Treatment, Genomic Testing, and Outcomes of Pancreatic Cancer in Hispanic and Non-Hispanic Patients. | J Racial Ethn Health Disparities | 2023 | 37071331 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=28